UroGen Pharma
URGN
URGN
31 hedge funds and large institutions have $145M invested in UroGen Pharma in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.27% less ownership
Funds ownership: 39.41% → 35.14% (-4.3%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.9M | |
| 2 | +$3.15M | |
| 3 | +$2.35M | |
| 4 |
BII
Bainco International Investors
Boston,
Massachusetts
|
+$2.28M |
| 5 |
LSC
Lyon Street Capital
Sausalito,
California
|
+$1.32M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$6.36M | |
| 3 | -$903K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$899K |
| 5 |
Jennison Associates
New York
|
-$846K |